Literature DB >> 14743668

Pulmonary tuberculosis: relationship between sputum bacilloscopy and radiological lesions.

Mauro Gomes1, Roberto Saad Júnior, Roberto Stirbulov.   

Abstract

OBJECTIVES: To determine the frequency of radiological manifestations of chest tuberculosis among the tuberculosis outpatients at the Santa Casa de Misericórdia de São Paulo Hospital, and to correlate these radiological findings with the sputum bacilloscopy. SAMPLE AND METHODS: A review was made of the medical record cards and chest X-rays of all patients attended between January 1996 and December 1998. Patients with a diagnosis of tuberculosis who presented intrathoracic manifestations of the disease and negative anti-HIV serology were selected.
RESULTS: The selection included 153 patients, with an average age of 37.5 years, who were predominantly male (60.8%) and white (56.9%). Pulmonary lesions were present in 121 (79.9%) and extrapulmonary lesions in 32 (20.1%). Parenchymal-infiltrate lesions appeared in 56 patients (36.6%), cavity lesions in 55 (36.0%), pleural effusion in 28 (18.3%), isolated nodules in 6 (3.9%), mediastinal enlargement in 4 (2.6%) and miliary pattern in 4 (2.6%). Cavities were present in 45.5% of the patients with pulmonary lesions, generally in association with the parenchymal-infiltrate lesions. Parenchymal infiltrate was present in 86.8% of the patients with pulmonary lesions. There was significant presence of alcohol-acid resistant bacillus in the sputum of patients with cavities (76.4%), in comparison with those without cavities (50%) (p = 0.003).
CONCLUSIONS: Parenchymal-infiltrate lesions are the most frequent radiological manifestation of pulmonary tuberculosis, and they are generally associated with cavities. There is a relationship between the presence of acid fast bacilli in sputum and pulmonary cavity lesions.

Entities:  

Mesh:

Year:  2003        PMID: 14743668     DOI: 10.1590/s0036-46652003000500007

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  7 in total

1.  Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.

Authors:  Amador Goodridge; Carla Cueva; Maureen Lahiff; Grace Muzanye; John L Johnson; Payam Nahid; Lee W Riley
Journal:  Tuberculosis (Edinb)       Date:  2012-03-10       Impact factor: 3.131

2.  Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis.

Authors:  Moises Palaci; Reynaldo Dietze; David Jamil Hadad; Fabiola Karla Corrêa Ribeiro; Renata Lyrio Peres; Solange Alves Vinhas; Ethel Leonor Noia Maciel; Valdério do Valle Dettoni; Libby Horter; W Henry Boom; John L Johnson; Kathleen D Eisenach
Journal:  J Clin Microbiol       Date:  2007-10-10       Impact factor: 5.948

Review 3.  Cavitary tuberculosis: the gateway of disease transmission.

Authors:  Michael E Urbanowski; Alvaro A Ordonez; Camilo A Ruiz-Bedoya; Sanjay K Jain; William R Bishai
Journal:  Lancet Infect Dis       Date:  2020-05-05       Impact factor: 25.071

4.  Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.

Authors:  John L Johnson; David Jamil Hadad; Reynaldo Dietze; Ethel Leonor Noia Maciel; Barrett Sewali; Phineas Gitta; Alphonse Okwera; Roy D Mugerwa; Mary Rose Alcaneses; Maria Imelda Quelapio; Thelma E Tupasi; Libby Horter; Sara M Debanne; Kathleen D Eisenach; W Henry Boom
Journal:  Am J Respir Crit Care Med       Date:  2009-06-19       Impact factor: 21.405

5.  Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.

Authors:  Juliet Namugenyi; Joseph Musaazi; Achilles Katamba; Joan Kalyango; Emmanuel Sendaula; Andrew Kambugu; Jan Fehr; Barbara Castelnouvo; Yukari C Manabe; Willy Ssengooba; Christine Sekaggya-Wiltshire
Journal:  BMC Infect Dis       Date:  2021-06-01       Impact factor: 3.090

6.  Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment.

Authors:  Melissa R Nyendak; Byung Park; Megan D Null; Joy Baseke; Gwendolyn Swarbrick; Harriet Mayanja-Kizza; Mary Nsereko; Denise F Johnson; Phineas Gitta; Alphonse Okwera; Stefan Goldberg; Lorna Bozeman; John L Johnson; W Henry Boom; Deborah A Lewinsohn; David M Lewinsohn
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

7.  Outcomes of extended duration therapy for drug-susceptible cavitary pulmonary tuberculosis.

Authors:  Hyun Lee; Jang Won Sohn; Yun Su Sim; Tae Rim Shin; Dong-Gyu Kim; Hayoung Choi
Journal:  Ann Transl Med       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.